IPO Trending
CORONAEQ / NSE, BSEListed
Corona Remedies

Corona Remedies Limited, incorporated in August 2004, is a pharmaceutical company engaged in the development, manufacturing, and marketing of products across key therapeutic areas including women’s healthcare, cardiology, pain management, urology, and multispecialty segments. As of December 2024, its portfolio includes 67 brands covering women’s health, cardio-diabetic care, pain relief, urology, and multispecialty products such as vitamins, minerals, nutrition, gastrointestinal, and respiratory medications. The company has established a strong pan-India presence with 2,598 medical representatives across 22 states, ensuring deep engagement with healthcare professionals and hospitals. It operates two manufacturing facilities in Gujarat, supporting its production and quality-focused growth strategy in the Indian Pharmaceutical Market.

₹1,008 - ₹1,062144.49x sub
Listed Price₹1470.00
Listing Gain+38.42%

Subscription Status

144.49xTotal Demand
Updated 20 Oct 2026, 01:30 AM
QIB293.80x
🔥 Blockbuster Sizzling Demand!Offered: 12,21,729 sh
Nib220.18x
🔥 Blockbuster Sizzling Demand!Offered: 9,16,960 sh
Hnis(10l +)246.67x
🔥 Blockbuster Sizzling Demand!Offered: 6,11,307 sh
Hnis (2-10l)167.20x
🔥 Blockbuster Sizzling Demand!Offered: 3,05,653 sh
Retail30.29x
🔥 Blockbuster Sizzling Demand!Offered: 21,39,573 sh
Employees15.56x
Hot Bidding (High Profits)Offered: 58,036 sh
CategoryOfferedAppliedTimes
QIB12,21,72935,89,39,448293.8x
Nib9,16,96020,18,97,066220.18x
Hnis(10l +)6,11,30715,07,93,356246.67x
Hnis (2-10l)3,05,6535,11,03,710167.2x
Retail21,39,5736,48,02,05230.29x
Employees58,0369,02,88815.56x

Segment Subscription Demand

Segment / CategoryDemand (Shares)Offered (Shares)Times Sub.
QIB38,119.37129.75293.79x
Fis0.810Open
Others11.640Open
Retail6,881.98227.2230.29x
Hnis 2+5,427.2132.46167.20x
Hnis 10+16,014.2564.92246.68x
Employees95.896.1615.57x

Application-wise Breakup

CategoryReservedAppliedTimes Sub.
Retail1,52,82737,92,24824.81x
Employees035,988Open
Hnis(10l +)3,1191,55,22449.77x
Hnis (2-10l)1,5592,49,992160.35x
Bidding status cross-verified with live IPO subscription numbers ↗BSE & NSE Bidding Portal Feed

About Corona Remedies IPO Subscription Demand

Live subscription status and bidding analysis for Corona Remedies (CORONA) IPO. The issue is subscribed 144.49x overall across Qualified Institutional Buyers (QIB), Non-Institutional Investors (NII/HNI), and Retail Individual Investors (RII). Check real-time grey market demand on our GMP Tracker or review full issue details, lot size, and price band on the IPO Details Page.

Frequently Asked Questions